Parimala Nacharaju
Research Subjects
Research Interests
Parimala Nacharaju has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Adam H. Kramer
Department of Physiology and Biophysics
1 shared publication - David J. Sharp
MicroCures Inc
1 shared publication - Guillermo A. Villegas
Department of Urology
1 shared publication Hongying Liang
Department of Physiology and Biophysics, Albert Einstein College of Medicine, Bronx, NY
1 shared publicationJennifer T. Aguilan
Department of Pathology, Albert Einstein College of medicine, Bronx, NY; Laboratory for Macromolecular Analysis & Proteomics, Albert Einstein College of Medicine, Bronx, NY
1 shared publicationJoel M. Friedman
Department of Physiology and Biophysics, Albert Einstein College of Medicine, Bronx, NY
1 shared publication
Latest Publications
- Open Access
- 10 May 2021
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 6 (9)
Fidgetin-like 2 negatively regulates axonal growth and can be targeted to promote functional nerve regeneration
The microtubule (MT) cytoskeleton plays a critical role in axon growth and guidance. Here, we identify the MT-severing enzyme fidgetin-like 2 (FL2) as a negative regulator of axon regeneration and a therapeutic target for promoting nerve regeneration after injury. Genetic knockout of FL2 in cultured adult dorsal root ganglion neurons resulted in longer axons and attenuated growth cone retraction in response to inhibitory molecules. Given the axonal growth-promoting effects of FL2 depletion in vitro, we tested whether FL2 could be targeted to promote regeneration in a rodent model of cavernous nerve (CN) injury. The CNs are parasympathetic nerves that regulate blood flow to the penis, which are commonly damaged during radical prostatectomy (RP), resulting in erectile dysfunction (ED). Application of FL2-siRNA after CN injury significantly enhanced functional nerve recovery. Remarkably, following bilateral nerve transection, visible and functional nerve regeneration was observed in 7 out of 8 animals treated with FL2-siRNA, while no control-treated animals exhibited regeneration. These studies identify FL2 as a promising therapeutic target for enhancing regeneration after peripheral nerve injury and for mitigating neurogenic ED after RP — a condition for which, at present, only poor treatment options exist.
- 10 May 2021
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 6 (9)
Open AccessFidgetin-like 2 negatively regulates axonal growth and can be targeted to promote functional nerve regeneration
The microtubule (MT) cytoskeleton plays a critical role in axon growth and guidance. Here, we identify the MT-severing enzyme fidgetin-like 2 (FL2) as a negative regulator of axon regeneration and a therapeutic target for promoting nerve regeneration after injury. Genetic knockout of FL2 in cultured adult dorsal root ganglion neurons resulted in longer axons and attenuated growth cone retraction in response to inhibitory molecules. Given the axonal growth-promoting effects of FL2 depletion in vitro, we tested whether FL2 could be targeted to promote regeneration in a rodent model of cavernous nerve (CN) injury. The CNs are parasympathetic nerves that regulate blood flow to the penis, which are commonly damaged during radical prostatectomy (RP), resulting in erectile dysfunction (ED). Application of FL2-siRNA after CN injury significantly enhanced functional nerve recovery. Remarkably, following bilateral nerve transection, visible and functional nerve regeneration was observed in 7 out of 8 animals treated with FL2-siRNA, while no control-treated animals exhibited regeneration. These studies identify FL2 as a promising therapeutic target for enhancing regeneration after peripheral nerve injury and for mitigating neurogenic ED after RP — a condition for which, at present, only poor treatment options exist.
- 1 August 2019
- Published by Elsevier in Nanomedicine: Nanotechnology, Biology and Medicine
- Vol. 20, 102009
Anti-biofilm activity of garlic extract loaded nanoparticles
- 1 August 2019
- Published by Elsevier in Nanomedicine: Nanotechnology, Biology and Medicine
- Vol. 20, 102009
Anti-biofilm activity of garlic extract loaded nanoparticles